(Q39630896)

13 September 2017

title

Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

Hsien-Chia Juan

1

1 reference

13 September 2017

Hsin-Ting Tsai

2

1 reference

13 September 2017

Po-Hao Chang

3

1 reference

13 September 2017

Chi-Ying F Huang

4

1 reference

13 September 2017

Cheng-Po Hu

5

1 reference

13 September 2017

Fen-Hwa Wong

6

1 reference

13 September 2017

publication date

1 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

16

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

174-183

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-010-0555-z

13 September 2017

exact match

0 references

cites work

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

HBXIP functions as a cofactor of survivin in apoptosis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Survivin mediates resistance to antiandrogen therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Regulation of survivin function by Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Hsp60 regulation of tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-010-0555-Z

10.1007/S10495-010-0555-Z

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference